# Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

> **NCT05946538** · NA · UNKNOWN · sponsor: **AusDiagnostics Pty Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- Respiratory Viral Infection

## Interventions

- **DIAGNOSTIC_TEST:** SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
- **DIAGNOSTIC_TEST:** BioFire Respiratory Panel 2.1

## Key facts

- **NCT ID:** NCT05946538
- **Lead sponsor:** AusDiagnostics Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07
- **Primary completion:** 2024-02
- **Final completion:** 2024-02
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946538, "Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT05946538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*